Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Hogan

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
BMC Nephrology|February 20, 2019
Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort studyDimitrios Chanouzas, Julie Anne G McGregor, Peter Nightingale, et al.
Kidney International|December 17, 2013
Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathyTaewoo Lee, Andrea K Biddle, Sofia Lionaki, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2019
Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated VasculitisEveline Y Wu, Elizabeth A McInnis, Sonia Boyer-Suavet, et al.
Kidney International|May 25, 2020
ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activationBritta E Jones, Carolina A Herrera, Christian Agosto-Burgos, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2022
Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease ActivityDhruti P Chen, Elizabeth A McInnis, Eveline Y Wu, et al.
Kidney International|December 24, 2010
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeDebbie S Gipson, Howard Trachtman, Frederick J Kaskel, et al.
The Journal of Clinical Investigation|April 4, 2013
Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitisAleeza J Roth, Joshua D Ooi, Jacob J Hess, et al.
Kidney International|July 8, 2011
Clinical trial of focal segmental glomerulosclerosis in children and young adultsDebbie S Gipson, Howard Trachtman, Frederick J Kaskel, et al.
Journal of Autoimmunity|August 7, 2019
Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitisMeghan E Free, Katherine G Stember, Jacob J Hess, et al.
Kidney Medicine|April 11, 2025
Clinical Decision-Making About Immunosuppressive Treatment in Focal Segmental GlomerulosclerosisBrooke Blazius, Jonathan P Troost, Jeffrey B Kopp, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
BMC Nephrology|February 20, 2019
Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort studyDimitrios Chanouzas, Julie Anne G McGregor, Peter Nightingale, et al.
Kidney International|December 17, 2013
Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathyTaewoo Lee, Andrea K Biddle, Sofia Lionaki, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2019
Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated VasculitisEveline Y Wu, Elizabeth A McInnis, Sonia Boyer-Suavet, et al.
Kidney International|May 25, 2020
ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activationBritta E Jones, Carolina A Herrera, Christian Agosto-Burgos, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2022
Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease ActivityDhruti P Chen, Elizabeth A McInnis, Eveline Y Wu, et al.
Kidney International|December 24, 2010
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeDebbie S Gipson, Howard Trachtman, Frederick J Kaskel, et al.
The Journal of Clinical Investigation|April 4, 2013
Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitisAleeza J Roth, Joshua D Ooi, Jacob J Hess, et al.
Kidney International|July 8, 2011
Clinical trial of focal segmental glomerulosclerosis in children and young adultsDebbie S Gipson, Howard Trachtman, Frederick J Kaskel, et al.
Journal of Autoimmunity|August 7, 2019
Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitisMeghan E Free, Katherine G Stember, Jacob J Hess, et al.
Kidney Medicine|April 11, 2025
Clinical Decision-Making About Immunosuppressive Treatment in Focal Segmental GlomerulosclerosisBrooke Blazius, Jonathan P Troost, Jeffrey B Kopp, et al.
Pageof 14